Logo image of ESRT

EMPIRE STATE REALTY TRUST-A (ESRT) Stock Fundamental Analysis

USA - NYSE:ESRT - US2921041065 - REIT

7.45 USD
+0.16 (+2.19%)
Last: 11/7/2025, 8:04:00 PM
7.45 USD
0 (0%)
After Hours: 11/7/2025, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, ESRT scores 4 out of 10 in our fundamental rating. ESRT was compared to 127 industry peers in the Diversified REITs industry. ESRT has only an average score on both its financial health and profitability. ESRT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ESRT was profitable.
In the past year ESRT had a positive cash flow from operations.
In multiple years ESRT reported negative net income over the last 5 years.
In the past 5 years ESRT always reported a positive cash flow from operatings.
ESRT Yearly Net Income VS EBIT VS OCF VS FCFESRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

With a Return On Assets value of 0.99%, ESRT perfoms like the industry average, outperforming 53.54% of the companies in the same industry.
ESRT has a Return On Equity (3.79%) which is in line with its industry peers.
The Return On Invested Capital of ESRT (3.01%) is comparable to the rest of the industry.
ESRT had an Average Return On Invested Capital over the past 3 years of 2.75%. This is in line with the industry average of 3.07%.
The last Return On Invested Capital (3.01%) for ESRT is above the 3 year average (2.75%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.99%
ROE 3.79%
ROIC 3.01%
ROA(3y)1.03%
ROA(5y)0.49%
ROE(3y)4.33%
ROE(5y)2.08%
ROIC(3y)2.75%
ROIC(5y)2.24%
ESRT Yearly ROA, ROE, ROICESRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6

1.3 Margins

Looking at the Profit Margin, with a value of 5.26%, ESRT is in line with its industry, outperforming 52.76% of the companies in the same industry.
In the last couple of years the Profit Margin of ESRT has declined.
Looking at the Operating Margin, with a value of 19.41%, ESRT is in line with its industry, outperforming 44.88% of the companies in the same industry.
ESRT's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 54.42%, ESRT is doing worse than 74.02% of the companies in the same industry.
In the last couple of years the Gross Margin of ESRT has remained more or less at the same level.
Industry RankSector Rank
OM 19.41%
PM (TTM) 5.26%
GM 54.42%
OM growth 3Y14.11%
OM growth 5Y-0.46%
PM growth 3YN/A
PM growth 5Y-1.77%
GM growth 3Y-0.96%
GM growth 5Y-0.19%
ESRT Yearly Profit, Operating, Gross MarginsESRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

4

2. Health

2.1 Basic Checks

ESRT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ESRT has more shares outstanding than it did 1 year ago.
ESRT has less shares outstanding than it did 5 years ago.
ESRT has a worse debt/assets ratio than last year.
ESRT Yearly Shares OutstandingESRT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ESRT Yearly Total Debt VS Total AssetsESRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 0.61, we must say that ESRT is in the distress zone and has some risk of bankruptcy.
ESRT has a Altman-Z score of 0.61. This is comparable to the rest of the industry: ESRT outperforms 54.33% of its industry peers.
A Debt/Equity ratio of 1.93 is on the high side and indicates that ESRT has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.93, ESRT is doing worse than 69.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.93
Debt/FCF N/A
Altman-Z 0.61
ROIC/WACC0.5
WACC6.01%
ESRT Yearly LT Debt VS Equity VS FCFESRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

ESRT has a Current Ratio of 2.37. This indicates that ESRT is financially healthy and has no problem in meeting its short term obligations.
ESRT's Current ratio of 2.37 is amongst the best of the industry. ESRT outperforms 86.61% of its industry peers.
A Quick Ratio of 2.37 indicates that ESRT has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.37, ESRT belongs to the top of the industry, outperforming 86.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.37
Quick Ratio 2.37
ESRT Yearly Current Assets VS Current LiabilitesESRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 37.50% over the past year.
The Earnings Per Share has been decreasing by -8.83% on average over the past years.
ESRT shows a small growth in Revenue. In the last year, the Revenue has grown by 0.45%.
Measured over the past years, ESRT shows a small growth in Revenue. The Revenue has been growing by 0.98% on average per year.
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5Y-8.83%
EPS Q2Q%187.5%
Revenue 1Y (TTM)0.45%
Revenue growth 3Y7.16%
Revenue growth 5Y0.98%
Sales Q2Q%-20.64%

3.2 Future

The Earnings Per Share is expected to decrease by -37.27% on average over the next years. This is quite bad
ESRT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.75% yearly.
EPS Next Y-88.67%
EPS Next 2Y-68.83%
EPS Next 3Y-56.74%
EPS Next 5Y-37.27%
Revenue Next Year0.75%
Revenue Next 2Y1.81%
Revenue Next 3Y1.71%
Revenue Next 5Y1.75%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ESRT Yearly Revenue VS EstimatesESRT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M
ESRT Yearly EPS VS EstimatesESRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.2 0.4 0.6 0.8

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.47, which indicates a very decent valuation of ESRT.
Based on the Price/Earnings ratio, ESRT is valued cheaply inside the industry as 98.43% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 25.83, ESRT is valued rather cheaply.
A Price/Forward Earnings ratio of 121.73 indicates a quite expensive valuation of ESRT.
ESRT's Price/Forward Earnings is on the same level as the industry average.
ESRT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 32.68.
Industry RankSector Rank
PE 8.47
Fwd PE 121.73
ESRT Price Earnings VS Forward Price EarningsESRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ESRT is valued cheaply inside the industry as 87.40% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.57
ESRT Per share dataESRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A cheap valuation may be justified as ESRT's earnings are expected to decrease with -56.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-68.83%
EPS Next 3Y-56.74%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.92%, ESRT has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 6.31, ESRT's dividend is way lower than its industry peers. On top of this 88.98% of the companies listed in the same industry pay a better dividend than ESRT!
ESRT's Dividend Yield is comparable with the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 1.92%

5.2 History

The dividend of ESRT decreases each year by -17.38%.
ESRT has been paying a dividend for at least 10 years, so it has a reliable track record.
ESRT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-17.38%
Div Incr Years0
Div Non Decr Years3
ESRT Yearly Dividends per shareESRT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

ESRT pays out 68.41% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of ESRT has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP68.41%
EPS Next 2Y-68.83%
EPS Next 3Y-56.74%
ESRT Yearly Income VS Free CF VS DividendESRT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M
ESRT Dividend Payout.ESRT Dividend Payout, showing the Payout Ratio.ESRT Dividend Payout.PayoutRetained Earnings

EMPIRE STATE REALTY TRUST-A

NYSE:ESRT (11/7/2025, 8:04:00 PM)

After market: 7.45 0 (0%)

7.45

+0.16 (+2.19%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-29 2025-10-29/amc
Earnings (Next)02-17 2026-02-17/amc
Inst Owners98.25%
Inst Owner Change1.94%
Ins Owners0.08%
Ins Owner Change0%
Market Cap1.26B
Revenue(TTM)766.65M
Net Income(TTM)40.45M
Analysts75
Price Target9.04 (21.34%)
Short Float %3.44%
Short Ratio3.89
Dividend
Industry RankSector Rank
Dividend Yield 1.92%
Yearly Dividend0.17
Dividend Growth(5Y)-17.38%
DP68.41%
Div Incr Years0
Div Non Decr Years3
Ex-Date09-15 2025-09-15 (0.035)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.21%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-22.22%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)-1.48%
Valuation
Industry RankSector Rank
PE 8.47
Fwd PE 121.73
P/S 1.64
P/FCF N/A
P/OCF 4.81
P/B 1.18
P/tB 4.73
EV/EBITDA 9.57
EPS(TTM)0.88
EY11.81%
EPS(NY)0.06
Fwd EY0.82%
FCF(TTM)-0.87
FCFYN/A
OCF(TTM)1.55
OCFY20.79%
SpS4.53
BVpS6.3
TBVpS1.58
PEG (NY)N/A
PEG (5Y)N/A
Graham Number11.17
Profitability
Industry RankSector Rank
ROA 0.99%
ROE 3.79%
ROCE 3.81%
ROIC 3.01%
ROICexc 3.08%
ROICexgc 3.9%
OM 19.41%
PM (TTM) 5.26%
GM 54.42%
FCFM N/A
ROA(3y)1.03%
ROA(5y)0.49%
ROE(3y)4.33%
ROE(5y)2.08%
ROIC(3y)2.75%
ROIC(5y)2.24%
ROICexc(3y)2.99%
ROICexc(5y)2.46%
ROICexgc(3y)3.81%
ROICexgc(5y)3.15%
ROCE(3y)3.48%
ROCE(5y)2.83%
ROICexgc growth 3Y18.9%
ROICexgc growth 5Y-2.68%
ROICexc growth 3Y19.87%
ROICexc growth 5Y-1.77%
OM growth 3Y14.11%
OM growth 5Y-0.46%
PM growth 3YN/A
PM growth 5Y-1.77%
GM growth 3Y-0.96%
GM growth 5Y-0.19%
F-Score7
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 1.93
Debt/FCF N/A
Debt/EBITDA 6.11
Cap/Depr 218.69%
Cap/Sales 53.45%
Interest Coverage 1.51
Cash Conversion 77.94%
Profit Quality N/A
Current Ratio 2.37
Quick Ratio 2.37
Altman-Z 0.61
F-Score7
WACC6.01%
ROIC/WACC0.5
Cap/Depr(3y)133.09%
Cap/Depr(5y)115.91%
Cap/Sales(3y)34.64%
Cap/Sales(5y)32.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.5%
EPS 3YN/A
EPS 5Y-8.83%
EPS Q2Q%187.5%
EPS Next Y-88.67%
EPS Next 2Y-68.83%
EPS Next 3Y-56.74%
EPS Next 5Y-37.27%
Revenue 1Y (TTM)0.45%
Revenue growth 3Y7.16%
Revenue growth 5Y0.98%
Sales Q2Q%-20.64%
Revenue Next Year0.75%
Revenue Next 2Y1.81%
Revenue Next 3Y1.71%
Revenue Next 5Y1.75%
EBIT growth 1Y-2.8%
EBIT growth 3Y22.28%
EBIT growth 5Y0.51%
EBIT Next Year124.98%
EBIT Next 3Y33.35%
EBIT Next 5Y20.13%
FCF growth 1Y-427.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.55%
OCF growth 3Y7.08%
OCF growth 5Y2.32%

EMPIRE STATE REALTY TRUST-A / ESRT FAQ

Can you provide the ChartMill fundamental rating for EMPIRE STATE REALTY TRUST-A?

ChartMill assigns a fundamental rating of 4 / 10 to ESRT.


What is the valuation status of EMPIRE STATE REALTY TRUST-A (ESRT) stock?

ChartMill assigns a valuation rating of 3 / 10 to EMPIRE STATE REALTY TRUST-A (ESRT). This can be considered as Overvalued.


How profitable is EMPIRE STATE REALTY TRUST-A (ESRT) stock?

EMPIRE STATE REALTY TRUST-A (ESRT) has a profitability rating of 4 / 10.


How financially healthy is EMPIRE STATE REALTY TRUST-A?

The financial health rating of EMPIRE STATE REALTY TRUST-A (ESRT) is 4 / 10.


What is the expected EPS growth for EMPIRE STATE REALTY TRUST-A (ESRT) stock?

The Earnings per Share (EPS) of EMPIRE STATE REALTY TRUST-A (ESRT) is expected to decline by -88.67% in the next year.